Diamond Hill Capital, an investment management company, released its “Large Cap Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. Despite inconsistent Q4 ...

Colgate-Palmolive and Introgen Therapeutics, Austin, Tex, biotechnology company, announce alliance to incorporate gene therapy into mouthwashes, gels and similar products to treat and prevent oral ...

Colgate-Palmolive Company CL is effectively leveraging its pricing power to support growth and mitigate external cost pressures. The company’s productivity program centers on cost savings and ...

We came across a bullish thesis on Colgate-Palmolive Company (CL) on Kontra Investment Xchange’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on CL. Colgate-Palmolive ...

After 2.5 years of work, Colgate-Palmolive unveiled the refreshed design and tagline “Make More Smiles” to employees in ...

Colgate-Palmolive Co.’s stock gave back early gains to trade flat on Friday, after the consumer goods giant beat first-quarter earnings estimates and raised its guidance. The company had net income of ...

Colgate-Palmolive remains a global leader in oral care, boasting strong brand equity, innovation. Read why I rate CL stock a Buy right now.

Colgate-Palmolive Company CL is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 24.29, higher than the industry average of 22.07X and the S&P 500’s 22.69X. This premium ...